Application of machine learning to arterial spin labeling in mild cognitive impairment and Alzheimer disease

Radiology

Volumn 281, Issue 3, 2016, Pages 865-875

  Collij, Lyduine E ^a   Heeman, Fiona ^a   Kuijer, Joost P A ^a   Ossenkoppele, Rik ^a   Benedictus, Marije R ^a   Möller, Christiane ^a   Verfaillie, Sander C J ^a   Sanz Arigita, Ernesto J ^a   Van Berckel, Bart N M ^a   Van Der Flier, Wiesje M ^a   Scheltens, Philip ^a   Barkhof, Frederik ^a   Wink, Alle Meije ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTERIAL SPIN LABELING; ARTICLE; BRAIN PERFUSION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; AGED; AREA UNDER THE CURVE; COGNITIVE DYSFUNCTION; EARLY DIAGNOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PATTERN RECOGNITION; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

SPIN LABEL;

AGED; ALZHEIMER DISEASE; AREA UNDER CURVE; COGNITIVE DYSFUNCTION; EARLY DIAGNOSIS; FEMALE; HUMANS; MACHINE LEARNING; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PATTERN RECOGNITION, VISUAL; SPIN LABELS;

EID: 84999828464     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016152703     Document Type: Article

References (35)

1. Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Alzheimers Dement 2014;10(2):e47-e92.
2. Murphy SL, Xu J, Kochanek KD. Deaths: Final data for 2010. Natl Vital Stat Rep 2013;61(4):1-117.
3. Morinaga A, Ono K, Ikeda T, et al. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic. Dement Geriatr Cogn Disord 2010;30(4):285-292.
4. Filippi M, Agosta F, Barkhof F, et al. EFNS task force: The use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012;19(12): E131-e140, 1487-1501.
5. Viola KL, Sbarboro J, Sureka R, et al. Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease. Nat Nanotechnol 2015;10(1):91-98.
6. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9(1):119-128.
7. Binnewijzend MA, Kuijer JP, van der Flier WM, et al. Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 2014;24(9):2326-2333.
8. Binnewijzend MA, Kuijer JP, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: A marker for disease severity. Radiology 2013;267(1):221-230.
9. Wolk DA, Detre JA. Arterial spin labeling MRI: An emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol 2012; 25(4):421-428.
10. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and Alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250(3):856-866.
11. Binnewijzend MA, Benedictus MR, Kuijer JP, et al. Cerebral perfusion in the predementia stages of Alzheimer's disease. Eur Radiol 2016;26(2):506-514.
12. Gray KR, Wolz R, Heckemann RA, et al. Multi-region analysis of longitudinal FDGPET for the classification of Alzheimer's disease. Neuroimage 2012;60(1):221-229.
13. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23(1):37-45.
14. Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73(1): 102-116.
15. Chen Y, Wolk DA, Reddin JS, et al. Voxellevel comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 2011;77(22):1977-1985.
16. Verfaillie S, Adriaanse SM, Binnewijzend M, et al. Resting state cerebral perfusion and metabolism in subjective memory complaints: Alzheimer's disease and frontotemporal dementia'two sides of the same coin?. Alzheimers Dement 2014;10(4 Suppl): P543.
17. Klöppel S, Stonnington CM, Chu C, et al. Automatic classification of MR scans in Alzheimer's disease. Brain 2008;131(Pt 3):681-689.
18. Vemuri P, Gunter JL, Senjem ML, et al. Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies. Neuroimage 2008;39(3):1186-1197.
19. DeCarli C, Frisoni GB, Clark CM, et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007;64(1):108-115.
20. Teipel SJ, Born C, Ewers M, et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 2007;38(1):13-24.
21. Schrouff J, Rosa MJ, Rondina JM, et al. PRoNTo: Pattern recognition for neuroimaging toolbox. Neuroinformatics 2013;11(3): 319-337.
22. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45(1):17-23.
23. La Joie R, Perrotin A, Barré L, et al. Region-specific hierarchy between atrophy, hypometabolism, and b-amyloid (Ab) load in Alzheimer's disease dementia. J Neurosci 2012;32(46):16265-16273.
24. van der Flier WM, Pijnenburg YA, Prins N, et al. Optimizing patient care and research: The Amsterdam Dementia Cohort. J Alzheimers Dis 2014;41(1):313-327.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-944.
26. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56(3):303-308.
27. Verhage F. Intelligentie en leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventigjaar [thesis]. Assen, the Netherlands: Van Gorcum, 1964.
28. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40(3):383-396.
29. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl 1):S208-S219.
30. Pase MP, Grima NA, Stough C, Scholey A, Pipingas A. Association of pulsatile and mean cerebral blood flow velocity with age and neuropsychological performance. Physiol Behav 2014;130:23-27.
31. Vapnik V. The nature of statistical learning theory. New York, NY: Springer Verlag, 1995.
32. Kukull WA, Ganguli M. Generalizability: The trees, the forest, and the low-hanging fruit. Neurology 2012;78(23):1886-1891.
33. Klöppel S, Abdulkadir A, Jack CR Jr, Koutsouleris N, Mourão-Miranda J, Vemuri P. Diagnostic neuroimaging across diseases. Neuroimage 2012;61(2):457-463.
34. Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: An SPM analysis of 120 patients. Brain 2005;128(Pt 8):1790-1801.
35. Kemp PM, Holmes C, Hoffmann SM, et al. Alzheimer's disease: Differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 2003;74(6): 715-719.